Epigenetics meets AI.
Medicine meets the
future.
Humanity is now beginning to unravel the root causes of aging—and learning how to reverse them.
Conventional medicine has long focused on treating illness only after it occurs.
Epigenetics, the mechanism that controls gene expression after birth, combined with our proprietary large-scale AI foundation model.Integrating these to realize precision predictive medicine.
Predicting future risks and delivering certainty for lifelong health.Extending human healthspan, bringing the gap between healthspan and lifespan ever closer to zero.
For a world where aging brings nothing but joy.
- Company Name
-
Epigenetic AI Inc.
- Established
-
June 3, 2025
- Representatives
-
Makoto Koyama, Co-Founder/Co-CEO
Taizo Son, Co-Founder/Co-CEO
- Location
-
Atagoyama PREX 10F, 3-25-31 Nishi-Shinbashi, Minato-ku, Tokyo
M.D., Ph.D.
Emeritus Professor, Kyoto Prefectural University of Medicine
Honorary Chairman, Japanese Society of Anti-Aging Medicine
M.D., Ph.D.
Specially Appointed Professor
(full time)
Center for Preventive Medicine,
Keio University
Professor Emeritus of Keio University
Ph.D.
Professor, Kyoto University
Ph.D.
Professor, University of Tokyo
M.D., Ph.D.
Endowed Chair Professor, Juntendo University
Ph.D.
Professor Emeritus, The University of Osaka